We are live on ! Find out more
BCI

Bain Capital Investors Portfolio holdings

AUM $3.27B
1-Year Est. Return 3.23%
This Fund
S&P 500
This Quarter Est. Return
+23.15%
1 Year Est. Return
+3.23%
3 Year Est. Return
+87.05%
5 Year Est. Return
+97.69%
10 Year Est. Return
+813.76%
AUM
$6.67B
AUM Growth
+$1.17B
Cap. Flow
-$13.3M
Cap. Flow %
-0.2%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 70.08%
2 Consumer Staples 29.82%
3 Communication Services 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGRY icon
1
Surgery Partners
SGRY
$1.96B
$2.62B 39.31%
58,248,249
– –
DSEY
2
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$1.99B 29.82%
236,983,211
– –
CERE
3
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$1.91B 28.7%
60,199,729
-432,627
-0.7% -$13.3M
AVAH icon
4
Aveanna Healthcare
AVAH
$1.95B
$138M 2.07%
81,600,880
– –
ADV icon
5
Advantage Solutions
ADV
$387M
$6.76M 0.1%
115,600
– –

Similar funds

AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return

Bain Capital Investors's Q2 2023 Portfolio in Review

As of Q2 2023, Bain Capital Investors held 5 positions worth $6.67B, up 21% from $5.49B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 0%. Bain Capital Investors opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 65% a quarter earlier, followed by Consumer Staples and Communication Services.

  • Bain Capital Investors's biggest Q2 2023 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $13.3M.
  • Bain Capital Investors's ten largest holdings make up 100% of its $6.67B portfolio in Q2 2023.
  • Bain Capital Investors opened 0 new positions and closed 0 in Q2 2023.
  • Bain Capital Investors's portfolio value rose 21% quarter-over-quarter to $6.67B.

Based on Bain Capital Investors's 13F filing for Q2 2023, filed 14 Aug 2023.